SCHEMBL4677657

SCHEMBL4677657

CCc1cn(Cc2ccccc2F)cc1C(=O)C=C(O)c1nn[nH]n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.35
KDM4A O75164 1/20 0.35
KDM5A P29375 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
NOD2 Q9HC29 1/20 0.34
ATM Q13315 1/20 0.33
ALDH1A1 P00352 6/20 0.33
HPGD P15428 1/20 0.33
NTRK1 P04629 1/20 0.33
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CES1 P23141 1/20 0.32
NCEH1 Q6PIU2 1/20 0.32
KDM4E B2RXH2 4/20 0.32
POLB P06746 1/20 0.32
MEN1 O00255 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4673837 0.90 CES1 (0.39) KDM4AKDM5AKDM4CKDM5BATM
SCHEMBL4675803 0.85 MAPT (0.33) PTGDR2KDM4AKDM5AKDM4CKDM5B
SCHEMBL4677400 0.84 KDM4A (0.37) KDM4AKDM5AKDM4CKDM5BNPC1
SCHEMBL4675325 0.84 PTGDR2 (0.37) PTGDR2KDM4CALDH1A1NTRK1RXFP1
SCHEMBL4678751 0.83 KDM4C (0.35) PTGDR2KDM4CALDH1A1CES1NCEH1
SCHEMBL4679413 0.82 KDM4A (0.38) PTGDR2KDM4AKDM5AKDM4CKDM5B
SCHEMBL4676225 0.82 AGTR1 (0.33) NPC1LMNA
SCHEMBL4694742 0.82 MEN1 (0.32) CES1NCEH1KDM4EMEN1KMT2A
SCHEMBL4675314 0.80 PTGDR2 (0.37) PTGDR2NPC1RAB9ANOD2ALDH1A1
SCHEMBL4670978 0.80 CDK5 (0.35) PTGDR2NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142872-B1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO (JP) 2008-10-15 EP disclosed
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6620841-B1 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) SHIONOGI & CO., LTD. (JP) 2003-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 PTGDR2 4591/4885KDM4A 340/4885KDM5A 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.